Document is current

Any future updates will be listed below

Adding brentuximab vedotin to lenalidomide and rituximab improves OS in R/R DLBCL

Crossref DOI link: https://doi.org/10.1038/s41571-025-00988-1

Published Online: 2025-01-20

Published Print: 2025-03

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark